Home
Search
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

U.S. voters favor strong IP protection
Good Day BIO Newsletter  •  January 18, 2024
A new poll finds most Americans want the Biden administration to protect IP rights on the international stage, and both consumers and investors are increasingly interested in products made from captured carbon. (560 words, 2 minutes, 48 seconds)
Read More

Signals from JPM Week for 2024 Business Development Planning
Webinars  •  January 18, 2024
Announcements around and during JPM Week each January often create waves throughout the biotechnology ecosystem. View this Biotechnology Innovation Organization (BIO) webinar to learn what experienced dealmakers and market analysts found most relevant and influential from JPM Week to consider when planning your own capital formation and partnering priorities for 2024. The discussion covers developments affecting M&A trends, the IPO window, licensing trends, biotech AI, and investor sentiment. This webinar will also preview the program for the BIO CEO & Investor Conference, February 26-27, and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities.
Read More
JPM 2020 image

Can we restore the R&D tax deduction?
Good Day BIO Newsletter  •  January 17, 2024
With a new bipartisan proposal to restore the full R&D tax deduction on the table, now’s the time for you to take action—we tell you how. Plus, five takeaways from BIO’s participation in JPM Week. (599 words, 2 minutes, 59 seconds)
Read More

Take action on R&D tax deductions
Good Day BIO Newsletter  •  January 16, 2024
ICYMI: R&D tax deductions are now amortized over five years—but you can take action to help restore R&D tax exemptions and support innovation. New York recently became the first state to regulate the treatment of seeds with neonicotinoids—here’s why it matters. (526 words, 2 minutes, 37 seconds)
Read More

BIO Partnering @JPM Week (Day 5)
January 12, 2024
Registration and the BIO One-on-One Partnering™ System are now open! BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
Read More

Billion-dollar disasters
Good Day BIO Newsletter  •  January 12, 2024
A recent analysis in Health Affairs explains why we need to restore orphan drug incentives, and a new report highlights the toll of the record number of climate-related disasters in the U.S. (433 words, 2 minutes, 9 seconds) We’re off on Monday in recognition of Martin Luther King Jr. Day. We’ll resume publication on Tuesday, January 16.
Read More

BIO Partnering @JPM Week (Day 4)
January 11, 2024
Registration and the BIO One-on-One Partnering™ System are now open! BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
Read More

Gene editing wild crops to feed the world
Good Day BIO Newsletter  •  January 11, 2024
New research highlights how gene editing can accelerate viable crops to feed the world, and CARB-X announces funding for AMR R&D. (399 words, 2 minutes)
Read More

BIO Partnering @JPM Week (Day 3)
January 10, 2024
Registration and the BIO One-on-One Partnering™ System are now open! BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
Read More

The second-highest surge
Good Day BIO Newsletter  •  January 10, 2024
We're in the midst of the second-highest COVID surge in the U.S.—but vaccines work, if people get them. New climate data released yesterday highlights the importance of advancing biotech solutions. (440 words, 2 minutes, 12 seconds)
Read More